基石药业-B(02616.HK) 公布,与医药公司SteinCares达成商业化战略合作。根据许可及商业化协定,SteinCares将获得舒格利单抗在十个拉丁美洲国家,包括巴西、阿根廷、墨西哥、智利、哥伦比亚、哥斯达黎加、巴拿马、秘鲁、危地马拉及厄瓜多尔的商业化权利。基石药业将获得首付款、注册与销售里程碑付款,以及通过在10个拉丁美洲国家向SteinCares销售舒格利单抗来获取收入。 这是基石...
Source Link基石药业-B(02616.HK) 公布,与医药公司SteinCares达成商业化战略合作。根据许可及商业化协定,SteinCares将获得舒格利单抗在十个拉丁美洲国家,包括巴西、阿根廷、墨西哥、智利、哥伦比亚、哥斯达黎加、巴拿马、秘鲁、危地马拉及厄瓜多尔的商业化权利。基石药业将获得首付款、注册与销售里程碑付款,以及通过在10个拉丁美洲国家向SteinCares销售舒格利单抗来获取收入。 这是基石...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.